Sone Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Buy
83,673
+43,610
+109% +$3.98M 0.58% 66
2026
Q1
$4.11M Buy
40,063
+35,554
+789% +$4.01M 0.35% 78
2025
Q4
$565K Buy
+4,509
New +$574K 0.05% 98
2025
Q3
Sell
-116,667
Closed -$15.9M 97
2025
Q2
$15.9M Buy
116,667
+100,912
+641% +$13.3M 1.46% 25
2025
Q1
$2.09M Sell
15,755
-96,094
-86% -$12.2M 0.22% 95
2024
Q4
$12.7M Buy
+111,849
New +$12.9M 1.6% 15

Other funds holding ABT

Sone Capital Management's ABT Position: Q2 2026 in Review

Sone Capital Management increased its Abbott (ABT) stake by 109% in Q2 2026, buying an estimated $3.98M and bringing the position to 83,673 shares worth $7.59M. The position accounts for 0.58% of the portfolio, ranked #66.

Sone Capital Management first reported a position in ABT in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.9M in Q2 2025. 2,970 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Sone Capital Management held 83,673 shares of Abbott worth $7.59M as of Q2 2026.
  • Sone Capital Management bought 43,610 Abbott shares in Q2 2026, an estimated $3.98M.
  • Abbott made up 0.58% of Sone Capital Management's portfolio in Q2 2026, its #66 holding.
  • Sone Capital Management first reported a position in Abbott in Q4 2024 and has held it in 6 quarters since.
  • Sone Capital Management's Abbott position peaked at $15.9M in Q2 2025.
  • 2,970 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Sone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.